442 - In utero xylazine exposure is associated with feeding difficulties in infants with Neonatal Opioid Withdrawal Syndrome

Stefanie Kelsey, Robert Larner, M.D., College of Medicine at the University of Vermont, Burlington, VT, United States; Mary-Kara Comeau, The University of Vermont Children's Hospital, Burlington, VT, United States; Olivia Buonanno, The University of Vermont Children's Hospital, Burlington, VT, United States; Leslie W. Young, University of Vermont Larner College of Medicine, Burlington, VT, United States; Adrienne Pahl, The University of Vermont Children's Hospital, Burlington, VT, United States; Julia F. Litzky, The University of Vermont Children's Hospital, Chittenden, VT, United States